
GEME targets the growth potential of emerging markets via a concentrated portfolio of 20-50 equity and equity-related securities. Investments include common stock, preferred stock, and ADRs from large- and mid-cap companies. The fund allocates a minimum of 40% of its assets across multiple non-US countries and 30% during unfavorable conditions. The selection process follows a value-driven approach, seeking undervalued companies trading below intrinsic value, using proprietary valuation models that combine top-down macroeconomic analysis with bottom-up company research. Holdings may include fixed-income securities, participatory notes for restricted markets, and China A-shares, capped at 10%. Additionally, it uses derivatives for currency hedging and may employ up to 15% leverage for long positions, with short positions at 20% strictly reserved for hedging. Positions are sold when they exceed intrinsic value, show deteriorating fundamentals, or increase portfolio risk.
Pacific North of South EM Equity Active ETF trades as GEME on NASDAQ. The company is classified in Financial Services / Asset Management and reports in USD.
The current profile places the business in Asset Management. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.
Detailed operating-segment data is not available for this symbol yet.
Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.
The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.
Pacific North of South EM Equity Active ETF can be compared against peers such as Xtrackers FTSE Developed ex US Multifactor ETF, Franklin FTSE Germany ETF, GMO US Value ETF, iShares International Developed Small Cap Value Factor ETF, Lazard Japanese Equity ETF, Invesco KBW Regional Banking ETF.
A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.
Current signals to investigate include market capitalization of $62.99M, beta of 1.04, and return on equity of N/A.
This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.
Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.
GEME currently shows total debt of N/A and beta of 1.04. Missing data should be treated as a research gap, not as low risk.
Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.
No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.
Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.
No recent SEC-style filings are available for this symbol yet.
Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.
Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.
Company website: https://www.pacificam.co.uk/geme-etf.
For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.